Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.625
Bid: 0.60
Ask: 0.65
Change: -0.125 (-16.67%)
Spread: 0.05 (8.333%)
Open: 0.75
High: 0.75
Low: 0.625
Prev. Close: 0.75
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Feb 2011 07:00

RNS Number : 5387B
Ultima Networks PLC
21 February 2011
 



21 February 2011

 

Ultima Networks plc

('Ultima' or the 'Company')

 

Appointment of Executive Director

 

The Board of Ultima is pleased to announce the appointment of Matteo Turi to its Board as an Executive Director of the Company with effect from 1 April 2011. Matteo will be responsible for the development of the Company's Green Power division and specifically for Ultima's solar power activities in Italy.

 

Matteo Turi (aged 39) is currently Finance Director at London-based RenGen Energy Group ("RenGen"), a renewable energy fund which sources, develops and finances renewable energy projects. RenGen's interests include equity and debt investments in renewable energy projects in Italy. Matteo joined RenGen in April 2008 where he has been, inter alia, responsible for all financial strategies and planning for RenGen's renewable energy investments. Matteo will initially continue to work with RenGen on a part-time basis.

 

Prior to joining RenGen, Matteo was European Financial Controller at K2 Partnering Solutions Ltd, a global provider of enterprise software consultants, from May 2007 to April 2008 where his role included business transformation and extensive change management. Previously Matteo was Divisional Financial Controller of Vanco plc, a Pan-European telecoms business, from May 1999 to March 2005 where he helped support the growth of Vanco during this period including the listing in 2001 of the company on the Official List of the London Stock Exchange. After leaving Vanco Matteo worked at International Poster Management, part of the Interpublic Group, as Divisional Financial Controller on a short term project and was Senior Overseas Financial Manager at Moneygram International Ltd where his role covered the integration of a major acquisition. Matteo has been a member of ACCA (the Association of Chartered Certified Accountants) since 2003.

 

Commenting on the board appointment, Prof. Humayun Mughal, the Company's Chairman and CEO, commented: "On behalf of the Board I would like to welcome Matteo onto the board and into his new role further strengthening our renewable energy capabilities. Matteo joins us with experience in the renewable energy sector at a time when we are looking to build upon our solar power credentials, particularly in Italy. We are confident that his experience will prove to be valuable to the growth of Ultima."

 

Matteo Turi is, or has been, a director of the following companies in the last 5 years:

 

Current Directorships/Partnerships:

 

Directorships/Partnerships within the last 5 years:

None

None

 

Matteo currently has no interest in the share capital of Ultima.

 

There are no further disclosures to be made in relation to Mr Matteo Turi under Schedule 2 (g) and rule 17 of the AIM Rules for Companies.

 

 

Ultima Networks plc

Prof. Humayun Mughal, Chairman and CEO

Tel: 01279 821 200

Allenby Capital Limited

(Nominated Adviser and Broker)

Tel: +44 (0)203 328 5656

Nick Naylor

Nick Athanas

Alex Price

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGZZMGVGMZZ
Date   Source Headline
24th Sep 20182:05 pmRNSSecond Price Monitoring Extn
24th Sep 20182:00 pmRNSPrice Monitoring Extension
24th Sep 20187:00 amRNSAcceptance of Nuvec® on EUNCL
20th Sep 20187:01 amRNSInterim Results
20th Sep 20187:00 amRNSStrategic Review
30th Jul 201811:05 amRNSSecond Price Monitoring Extn
30th Jul 201811:00 amRNSPrice Monitoring Extension
30th Jul 20187:00 amRNSChange of Adviser
17th Jul 20181:12 pmRNSHolding(s) in Company
11th Jul 20182:05 pmRNSSecond Price Monitoring Extn
11th Jul 20182:00 pmRNSPrice Monitoring Extension
9th Jul 20187:00 amRNSClinical trials preliminary results
18th Jun 20187:00 amRNSNuvec® Update
23rd May 201811:31 amRNSResult of AGM
9th May 20187:00 amRNSFiling of Patent
27th Apr 201811:00 amRNSPosting of Annual Report and Notice of AGM
25th Apr 20187:00 amRNSFinal Results
18th Apr 20187:00 amRNSCommencement of Sildenafil Clinical Trial
9th Apr 201811:00 amRNSPrice Monitoring Extension
9th Mar 20188:43 amRNSExercise of Warrants and Total Voting Rights
8th Mar 201810:05 amRNSHolding(s) in Company
8th Mar 20187:00 amRNSNuvec® Update
7th Mar 20188:33 amRNSExercise of Warrants and Total Voting Rights
2nd Mar 201812:17 pmRNSChange of Adviser
26th Feb 20189:27 amRNSExercise of Warrants and Total Voting Rights
21st Feb 20181:36 pmRNSExercise of Warrants and Total Voting Rights
19th Feb 20185:01 pmRNSExercise of Warrants and Total Voting Rights
14th Feb 20185:26 pmRNSExercise of Warrants and Total Voting Rights
13th Feb 201812:52 pmRNSExercise of Warrants and Total Voting Rights
12th Feb 20182:05 pmRNSSecond Price Monitoring Extn
12th Feb 20182:00 pmRNSPrice Monitoring Extension
12th Feb 201811:06 amRNSSecond Price Monitoring Extn
12th Feb 201811:00 amRNSPrice Monitoring Extension
8th Feb 201812:01 pmRNSHolding(s) in Company
8th Feb 201811:46 amRNSExercise of Warrants and Total Voting Rights
5th Feb 20187:00 amRNSIssue of Equity and Director/PDMR Shareholding
2nd Feb 20184:47 pmRNSExercise of Warrants and Total Voting Rights
2nd Feb 20181:04 pmRNSAward of Grant and Collaboration with MedImmune UK
30th Jan 20183:04 pmRNSExercise of Warrants and Total Voting Rights
24th Jan 20184:06 pmRNSExercise of Warrants and Total Voting Rights
24th Jan 20181:19 pmRNSGlobal Business Accelerator Programme in Japan
22nd Jan 201810:44 amRNSExercise of Warrants and Total Voting Rights
15th Jan 201812:36 pmRNSHolding(s) in Company
8th Jan 20182:31 pmRNSExercise of Warrants and Total Voting Rights
8th Jan 20181:26 pmRNSHolding(s) in Company
28th Dec 20179:03 amRNSExercise of Warrants and Total Voting Rights
22nd Dec 20177:00 amRNSFiling of Patent
18th Dec 20178:27 amRNSHolding(s) in Company
13th Dec 20174:07 pmRNSExercise of Warrants and Total Voting Rights
29th Nov 201711:12 amRNSViagra switch to OTC status in the UK

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.